Vr Adviser, LLC Arca Biopharma, Inc. Transaction History
Vr Adviser, LLC
- $912 Million
- Q2 2024
A detailed history of Vr Adviser, LLC transactions in Arca Biopharma, Inc. stock. As of the latest transaction made, Vr Adviser, LLC holds 866,375 shares of ABIO stock, worth $0. This represents 0.36% of its overall portfolio holdings.
Number of Shares
866,375Holding current value
$0% of portfolio
0.36%Shares
1 transactions
Others Institutions Holding ABIO
# of Institutions
37Shares Held
13MCall Options Held
41.6KPut Options Held
5.6K-
Cable Car Capital LLC San Francisco, CA4MShares$016.14% of portfolio
-
Rtw Investments, LP New York, NY1.4MShares$00.09% of portfolio
-
Janus Henderson Group PLC London, X01.38MShares$00.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.2MShares$00.01% of portfolio
-
Avidity Partners Management LP Dallas, TX1MShares$00.19% of portfolio
About ARCA biopharma, Inc.
- Ticker ABIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,410,100
- Description
- ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...